The cash flow of Belite Bio, Inc over the past 6 years
Chart Belite Bio, Inc: operating cash flow, capital expenditures, free cash flow, fiscal 2020–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Belite Bio, Inc's operating cash flow was -$36.99M and its capital expenditures $71K, leaving free cash flow of -$37.06M. Free cash flow was below zero in all 5 years shown. It ranged from -$37.06M in fiscal 2025 to -$7.55M in fiscal 2021. Capital expenditures were highest in fiscal 2022, at $394K.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$36.99M | $71K | -$37.06M |
| 2024ended Dec 31, 2024 | -$29.23M | $116K | -$29.35M |
| 2023ended Dec 31, 2023 | -$29.84M | $63K | -$29.9M |
| 2022ended Dec 31, 2022 | -$11.46M | $394K | -$11.85M |
| 2021ended Dec 31, 2021 | -$7.47M | $74K | -$7.55M |
| 2020ended Dec 31, 2020 | -$4.44M | — | — |
Fiscal years as Belite Bio, Inc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Belite Bio, Inc
- The profitability of Belite Bio, Inc
- The debt of Belite Bio, Inc
- All of Belite Bio, Inc's financials, charted
Companies of a similar size
- KBRKBR, Inc.
- OPCHOPTION CARE HEALTH, INC.
- OBDCBLUE OWL CAPITAL CORP
- PORPORTLAND GENERAL ELECTRIC COMPANY
- MAINMain Street Capital Corporation
Not investment advice. This page shows what Belite Bio, Inc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.